 | • レポートコード：MRC2Q12-18040 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、経口ワクチンアジュバントの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口ワクチンアジュバントのグローバル市場のxxx％を占める「動物用ワクチンアジュバント」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「研究用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 経口ワクチンアジュバントの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口ワクチンアジュバント市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 経口ワクチンアジュバントのグローバル主要プレイヤーには、SEPPIC、SDA BIO、Croda International、SPI Pharma、Phibro Animal Health Corporation、Tj Kaiwei、Novavax、Zhuoyue、Aphios、GSK、CSL、Brenntag Biosector、SEPPIC、SPI Pharma、Novavax、Avanti Polar Lipids、Aphiosなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 経口ワクチンアジュバント市場は、種類と用途によって区分されます。世界の経口ワクチンアジュバント市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 動物用ワクチンアジュバント、人間用ワクチンアジュバント 【用途別セグメント】 研究用、商業用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 経口ワクチンアジュバント製品概要 - 種類別市場（動物用ワクチンアジュバント、人間用ワクチンアジュバント） - 用途別市場（研究用、商業用） - 調査の目的 ・エグゼクティブサマリー - 世界の経口ワクチンアジュバント販売量予測2017-2028 - 世界の経口ワクチンアジュバント売上予測2017-2028 - 経口ワクチンアジュバントの地域別販売量 - 経口ワクチンアジュバントの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別経口ワクチンアジュバント販売量 - 主要メーカー別経口ワクチンアジュバント売上 - 主要メーカー別経口ワクチンアジュバント価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（動物用ワクチンアジュバント、人間用ワクチンアジュバント） - 経口ワクチンアジュバントの種類別販売量 - 経口ワクチンアジュバントの種類別売上 - 経口ワクチンアジュバントの種類別価格 ・用途別市場規模（研究用、商業用） - 経口ワクチンアジュバントの用途別販売量 - 経口ワクチンアジュバントの用途別売上 - 経口ワクチンアジュバントの用途別価格 ・北米市場 - 北米の経口ワクチンアジュバント市場規模（種類別、用途別） - 主要国別の経口ワクチンアジュバント市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの経口ワクチンアジュバント市場規模（種類別、用途別） - 主要国別の経口ワクチンアジュバント市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の経口ワクチンアジュバント市場規模（種類別、用途別） - 主要国別の経口ワクチンアジュバント市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の経口ワクチンアジュバント市場規模（種類別、用途別） - 主要国別の経口ワクチンアジュバント市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの経口ワクチンアジュバント市場規模（種類別、用途別） - 主要国別の経口ワクチンアジュバント市場規模（トルコ、サウジアラビア） ・企業情報 SEPPIC、SDA BIO、Croda International、SPI Pharma、Phibro Animal Health Corporation、Tj Kaiwei、Novavax、Zhuoyue、Aphios、GSK、CSL、Brenntag Biosector、SEPPIC、SPI Pharma、Novavax、Avanti Polar Lipids、Aphios ・産業チェーン及び販売チャネル分析 - 経口ワクチンアジュバントの産業チェーン分析 - 経口ワクチンアジュバントの原材料 - 経口ワクチンアジュバントの生産プロセス - 経口ワクチンアジュバントの販売及びマーケティング - 経口ワクチンアジュバントの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 経口ワクチンアジュバントの産業動向 - 経口ワクチンアジュバントのマーケットドライバー - 経口ワクチンアジュバントの課題 - 経口ワクチンアジュバントの阻害要因 ・主な調査結果 |
Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body’s specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body’s protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Oral Vaccine Adjuvants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Oral Vaccine Adjuvants include SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oral Vaccine Adjuvants manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Oral Vaccine Adjuvants market. Further, it explains the major drivers and regional dynamics of the global Oral Vaccine Adjuvants market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Oral Vaccine Adjuvants Segment by Type
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants
Oral Vaccine Adjuvants Segment by Application
Research Application
Commercial Application
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oral Vaccine Adjuvants market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Oral Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Oral Vaccine Adjuvants, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Vaccine Adjuvants, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Oral Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Oral Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Vaccine Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccine Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Oral Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Oral Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Veterinary Vaccine Adjuvants
1.2.3 Human Vaccine Adjuvants
1.3 Market by Application
1.3.1 Global Oral Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Application
1.3.3 Commercial Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Vaccine Adjuvants Sales by Region
2.4.1 Global Oral Vaccine Adjuvants Sales by Region (2017-2022)
2.4.2 Global Sales Oral Vaccine Adjuvants by Region (2023-2028)
2.5 Global Oral Vaccine Adjuvants Revenue by Region
2.5.1 Global Oral Vaccine Adjuvants Revenue by Region (2017-2022)
2.5.2 Global Oral Vaccine Adjuvants Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Vaccine Adjuvants Sales by Manufacturers
3.1.1 Global Top Oral Vaccine Adjuvants Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Vaccine Adjuvants in 2021
3.2 Global Oral Vaccine Adjuvants Revenue by Manufacturers
3.2.1 Global Oral Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Vaccine Adjuvants Revenue in 2021
3.3 Global Oral Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Vaccine Adjuvants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Vaccine Adjuvants Sales by Type
4.1.1 Global Oral Vaccine Adjuvants Historical Sales by Type (2017-2022)
4.1.2 Global Oral Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
4.2 Global Oral Vaccine Adjuvants Revenue by Type
4.2.1 Global Oral Vaccine Adjuvants Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
4.3 Global Oral Vaccine Adjuvants Price by Type
4.3.1 Global Oral Vaccine Adjuvants Price by Type (2017-2022)
4.3.2 Global Oral Vaccine Adjuvants Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Vaccine Adjuvants Sales by Application
5.1.1 Global Oral Vaccine Adjuvants Historical Sales by Application (2017-2022)
5.1.2 Global Oral Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
5.2 Global Oral Vaccine Adjuvants Revenue by Application
5.2.1 Global Oral Vaccine Adjuvants Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
5.3 Global Oral Vaccine Adjuvants Price by Application
5.3.1 Global Oral Vaccine Adjuvants Price by Application (2017-2022)
5.3.2 Global Oral Vaccine Adjuvants Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Vaccine Adjuvants Market Size by Type
6.1.1 North America Oral Vaccine Adjuvants Sales by Type (2017-2028)
6.1.2 North America Oral Vaccine Adjuvants Revenue by Type (2017-2028)
6.2 North America Oral Vaccine Adjuvants Market Size by Application
6.2.1 North America Oral Vaccine Adjuvants Sales by Application (2017-2028)
6.2.2 North America Oral Vaccine Adjuvants Revenue by Application (2017-2028)
6.3 North America Oral Vaccine Adjuvants Market Size by Country
6.3.1 North America Oral Vaccine Adjuvants Sales by Country (2017-2028)
6.3.2 North America Oral Vaccine Adjuvants Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Vaccine Adjuvants Market Size by Type
7.1.1 Europe Oral Vaccine Adjuvants Sales by Type (2017-2028)
7.1.2 Europe Oral Vaccine Adjuvants Revenue by Type (2017-2028)
7.2 Europe Oral Vaccine Adjuvants Market Size by Application
7.2.1 Europe Oral Vaccine Adjuvants Sales by Application (2017-2028)
7.2.2 Europe Oral Vaccine Adjuvants Revenue by Application (2017-2028)
7.3 Europe Oral Vaccine Adjuvants Market Size by Country
7.3.1 Europe Oral Vaccine Adjuvants Sales by Country (2017-2028)
7.3.2 Europe Oral Vaccine Adjuvants Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Vaccine Adjuvants Market Size by Type
8.1.1 Asia Pacific Oral Vaccine Adjuvants Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Vaccine Adjuvants Market Size by Application
8.2.1 Asia Pacific Oral Vaccine Adjuvants Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Vaccine Adjuvants Market Size by Region
8.3.1 Asia Pacific Oral Vaccine Adjuvants Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Vaccine Adjuvants Market Size by Type
9.1.1 Latin America Oral Vaccine Adjuvants Sales by Type (2017-2028)
9.1.2 Latin America Oral Vaccine Adjuvants Revenue by Type (2017-2028)
9.2 Latin America Oral Vaccine Adjuvants Market Size by Application
9.2.1 Latin America Oral Vaccine Adjuvants Sales by Application (2017-2028)
9.2.2 Latin America Oral Vaccine Adjuvants Revenue by Application (2017-2028)
9.3 Latin America Oral Vaccine Adjuvants Market Size by Country
9.3.1 Latin America Oral Vaccine Adjuvants Sales by Country (2017-2028)
9.3.2 Latin America Oral Vaccine Adjuvants Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccine Adjuvants Market Size by Type
10.1.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Vaccine Adjuvants Market Size by Application
10.2.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Vaccine Adjuvants Market Size by Country
10.3.1 Middle East and Africa Oral Vaccine Adjuvants Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Vaccine Adjuvants Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 SEPPIC
11.1.1 SEPPIC Corporation Information
11.1.2 SEPPIC Overview
11.1.3 SEPPIC Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 SEPPIC Recent Developments
11.2 SDA BIO
11.2.1 SDA BIO Corporation Information
11.2.2 SDA BIO Overview
11.2.3 SDA BIO Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 SDA BIO Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SDA BIO Recent Developments
11.3 Croda International
11.3.1 Croda International Corporation Information
11.3.2 Croda International Overview
11.3.3 Croda International Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Croda International Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Croda International Recent Developments
11.4 SPI Pharma
11.4.1 SPI Pharma Corporation Information
11.4.2 SPI Pharma Overview
11.4.3 SPI Pharma Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SPI Pharma Recent Developments
11.5 Phibro Animal Health Corporation
11.5.1 Phibro Animal Health Corporation Corporation Information
11.5.2 Phibro Animal Health Corporation Overview
11.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Phibro Animal Health Corporation Recent Developments
11.6 Tj Kaiwei
11.6.1 Tj Kaiwei Corporation Information
11.6.2 Tj Kaiwei Overview
11.6.3 Tj Kaiwei Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Tj Kaiwei Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tj Kaiwei Recent Developments
11.7 Novavax
11.7.1 Novavax Corporation Information
11.7.2 Novavax Overview
11.7.3 Novavax Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novavax Recent Developments
11.8 Zhuoyue
11.8.1 Zhuoyue Corporation Information
11.8.2 Zhuoyue Overview
11.8.3 Zhuoyue Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhuoyue Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhuoyue Recent Developments
11.9 Aphios
11.9.1 Aphios Corporation Information
11.9.2 Aphios Overview
11.9.3 Aphios Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aphios Recent Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Overview
11.10.3 GSK Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GSK Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 CSL
11.11.1 CSL Corporation Information
11.11.2 CSL Overview
11.11.3 CSL Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CSL Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CSL Recent Developments
11.12 Brenntag Biosector
11.12.1 Brenntag Biosector Corporation Information
11.12.2 Brenntag Biosector Overview
11.12.3 Brenntag Biosector Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Brenntag Biosector Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Brenntag Biosector Recent Developments
11.13 SEPPIC
11.13.1 SEPPIC Corporation Information
11.13.2 SEPPIC Overview
11.13.3 SEPPIC Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SEPPIC Recent Developments
11.14 SPI Pharma
11.14.1 SPI Pharma Corporation Information
11.14.2 SPI Pharma Overview
11.14.3 SPI Pharma Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 SPI Pharma Recent Developments
11.15 Novavax
11.15.1 Novavax Corporation Information
11.15.2 Novavax Overview
11.15.3 Novavax Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Novavax Recent Developments
11.16 Avanti Polar Lipids
11.16.1 Avanti Polar Lipids Corporation Information
11.16.2 Avanti Polar Lipids Overview
11.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Avanti Polar Lipids Recent Developments
11.17 Aphios
11.17.1 Aphios Corporation Information
11.17.2 Aphios Overview
11.17.3 Aphios Oral Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Aphios Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Vaccine Adjuvants Industry Chain Analysis
12.2 Oral Vaccine Adjuvants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Vaccine Adjuvants Production Mode & Process
12.4 Oral Vaccine Adjuvants Sales and Marketing
12.4.1 Oral Vaccine Adjuvants Sales Channels
12.4.2 Oral Vaccine Adjuvants Distributors
12.5 Oral Vaccine Adjuvants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Vaccine Adjuvants Industry Trends
13.2 Oral Vaccine Adjuvants Market Drivers
13.3 Oral Vaccine Adjuvants Market Challenges
13.4 Oral Vaccine Adjuvants Market Restraints
14 Key Findings in The Global Oral Vaccine Adjuvants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Oral Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Veterinary Vaccine Adjuvants
Table 3. Major Manufacturers of Human Vaccine Adjuvants
Table 4. Global Oral Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oral Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Vaccine Adjuvants Sales by Region (2017-2022) & (K Units)
Table 7. Global Oral Vaccine Adjuvants Sales Market Share by Region (2017-2022)
Table 8. Global Oral Vaccine Adjuvants Sales by Region (2023-2028) & (K Units)
Table 9. Global Oral Vaccine Adjuvants Sales Market Share by Region (2023-2028)
Table 10. Global Oral Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Vaccine Adjuvants Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oral Vaccine Adjuvants Revenue Market Share by Region (2023-2028)
Table 14. Global Oral Vaccine Adjuvants Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Oral Vaccine Adjuvants Sales Share by Manufacturers (2017-2022)
Table 16. Global Oral Vaccine Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oral Vaccine Adjuvants Revenue Share by Manufacturers (2017-2022)
Table 18. Oral Vaccine Adjuvants Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Oral Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oral Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccine Adjuvants as of 2021)
Table 21. Oral Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral Vaccine Adjuvants Product Offered
Table 23. Date of Manufacturers Enter into Oral Vaccine Adjuvants Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 26. Global Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 27. Global Oral Vaccine Adjuvants Sales Share by Type (2017-2022)
Table 28. Global Oral Vaccine Adjuvants Sales Share by Type (2023-2028)
Table 29. Global Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oral Vaccine Adjuvants Revenue Share by Type (2017-2022)
Table 32. Global Oral Vaccine Adjuvants Revenue Share by Type (2023-2028)
Table 33. Oral Vaccine Adjuvants Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Oral Vaccine Adjuvants Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 36. Global Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 37. Global Oral Vaccine Adjuvants Sales Share by Application (2017-2022)
Table 38. Global Oral Vaccine Adjuvants Sales Share by Application (2023-2028)
Table 39. Global Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oral Vaccine Adjuvants Revenue Share by Application (2017-2022)
Table 42. Global Oral Vaccine Adjuvants Revenue Share by Application (2023-2028)
Table 43. Oral Vaccine Adjuvants Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Oral Vaccine Adjuvants Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 46. North America Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 47. North America Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 50. North America Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 51. North America Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oral Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 54. North America Oral Vaccine Adjuvants Sales by Country (2023-2028) & (K Units)
Table 55. North America Oral Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oral Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 58. Europe Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 59. Europe Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 62. Europe Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 63. Europe Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oral Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 66. Europe Oral Vaccine Adjuvants Sales by Country (2023-2028) & (K Units)
Table 67. Europe Oral Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oral Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oral Vaccine Adjuvants Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Oral Vaccine Adjuvants Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oral Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oral Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Oral Vaccine Adjuvants Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Oral Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oral Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oral Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Oral Vaccine Adjuvants Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Oral Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oral Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oral Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Oral Vaccine Adjuvants Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Oral Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oral Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oral Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Oral Vaccine Adjuvants Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Oral Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oral Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
Table 105. SEPPIC Corporation Information
Table 106. SEPPIC Description and Major Businesses
Table 107. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. SEPPIC Recent Developments
Table 110. SDA BIO Corporation Information
Table 111. SDA BIO Description and Major Businesses
Table 112. SDA BIO Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. SDA BIO Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. SDA BIO Recent Developments
Table 115. Croda International Corporation Information
Table 116. Croda International Description and Major Businesses
Table 117. Croda International Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Croda International Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Croda International Recent Developments
Table 120. SPI Pharma Corporation Information
Table 121. SPI Pharma Description and Major Businesses
Table 122. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. SPI Pharma Recent Developments
Table 125. Phibro Animal Health Corporation Corporation Information
Table 126. Phibro Animal Health Corporation Description and Major Businesses
Table 127. Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Phibro Animal Health Corporation Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Phibro Animal Health Corporation Recent Developments
Table 130. Tj Kaiwei Corporation Information
Table 131. Tj Kaiwei Description and Major Businesses
Table 132. Tj Kaiwei Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Tj Kaiwei Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tj Kaiwei Recent Developments
Table 135. Novavax Corporation Information
Table 136. Novavax Description and Major Businesses
Table 137. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Novavax Recent Developments
Table 140. Zhuoyue Corporation Information
Table 141. Zhuoyue Description and Major Businesses
Table 142. Zhuoyue Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Zhuoyue Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Zhuoyue Recent Developments
Table 145. Aphios Corporation Information
Table 146. Aphios Description and Major Businesses
Table 147. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Aphios Recent Developments
Table 150. GSK Corporation Information
Table 151. GSK Description and Major Businesses
Table 152. GSK Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. GSK Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. GSK Recent Developments
Table 155. CSL Corporation Information
Table 156. CSL Description and Major Businesses
Table 157. CSL Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. CSL Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. CSL Recent Developments
Table 160. Brenntag Biosector Corporation Information
Table 161. Brenntag Biosector Description and Major Businesses
Table 162. Brenntag Biosector Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Brenntag Biosector Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Brenntag Biosector Recent Developments
Table 165. SEPPIC Corporation Information
Table 166. SEPPIC Description and Major Businesses
Table 167. SEPPIC Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. SEPPIC Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. SEPPIC Recent Developments
Table 170. SPI Pharma Corporation Information
Table 171. SPI Pharma Description and Major Businesses
Table 172. SPI Pharma Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. SPI Pharma Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. SPI Pharma Recent Developments
Table 175. Novavax Corporation Information
Table 176. Novavax Description and Major Businesses
Table 177. Novavax Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Novavax Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Novavax Recent Developments
Table 180. Avanti Polar Lipids Corporation Information
Table 181. Avanti Polar Lipids Description and Major Businesses
Table 182. Avanti Polar Lipids Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Avanti Polar Lipids Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Avanti Polar Lipids Recent Developments
Table 185. Aphios Corporation Information
Table 186. Aphios Description and Major Businesses
Table 187. Aphios Oral Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 188. Aphios Oral Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Aphios Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Oral Vaccine Adjuvants Distributors List
Table 193. Oral Vaccine Adjuvants Customers List
Table 194. Oral Vaccine Adjuvants Market Trends
Table 195. Oral Vaccine Adjuvants Market Drivers
Table 196. Oral Vaccine Adjuvants Market Challenges
Table 197. Oral Vaccine Adjuvants Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccine Adjuvants Product Picture
Figure 2. Global Oral Vaccine Adjuvants Market Share by Type in 2021 & 2028
Figure 3. Veterinary Vaccine Adjuvants Product Picture
Figure 4. Human Vaccine Adjuvants Product Picture
Figure 5. Global Oral Vaccine Adjuvants Market Share by Application in 2021 & 2028
Figure 6. Research Application
Figure 7. Commercial Application
Figure 8. Oral Vaccine Adjuvants Report Years Considered
Figure 9. Global Oral Vaccine Adjuvants Sales 2017-2028 (K Units)
Figure 10. Global Oral Vaccine Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Oral Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
Figure 12. Global Oral Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Oral Vaccine Adjuvants Sales Market Share by Region (2017-2022)
Figure 14. Global Oral Vaccine Adjuvants Sales Market Share by Region (2023-2028)
Figure 15. North America Oral Vaccine Adjuvants Sales YoY (2017-2028) & (K Units)
Figure 16. North America Oral Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Oral Vaccine Adjuvants Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Oral Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Oral Vaccine Adjuvants Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Oral Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Oral Vaccine Adjuvants Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Oral Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Oral Vaccine Adjuvants Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Oral Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Oral Vaccine Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Oral Vaccine Adjuvants in the World: Market Share by Oral Vaccine Adjuvants Revenue in 2021
Figure 27. Global Oral Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 29. Global Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 30. Global Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 31. Global Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 33. North America Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 34. North America Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 35. North America Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 36. North America Oral Vaccine Adjuvants Sales Share by Country (2017-2028)
Figure 37. North America Oral Vaccine Adjuvants Revenue Share by Country (2017-2028)
Figure 38. United States Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 41. Europe Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 42. Europe Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 43. Europe Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 44. Europe Oral Vaccine Adjuvants Sales Share by Country (2017-2028)
Figure 45. Europe Oral Vaccine Adjuvants Revenue Share by Country (2017-2028)
Figure 46. Germany Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 47. France Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral Vaccine Adjuvants Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Oral Vaccine Adjuvants Revenue Share by Region (2017-2028)
Figure 57. China Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 60. India Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 67. Latin America Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 69. Latin America Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Oral Vaccine Adjuvants Sales Share by Country (2017-2028)
Figure 71. Latin America Oral Vaccine Adjuvants Revenue Share by Country (2017-2028)
Figure 72. Mexico Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Oral Vaccine Adjuvants Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Oral Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Oral Vaccine Adjuvants Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Oral Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Oral Vaccine Adjuvants Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Oral Vaccine Adjuvants Revenue Share by Country (2017-2028)
Figure 82. Turkey Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Oral Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
Figure 85. Oral Vaccine Adjuvants Value Chain
Figure 86. Oral Vaccine Adjuvants Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed